Related Experiment Videos
Cytokines in tumour therapy.
A D Hill1, H P Redmond, D T Croke
1Department of Surgery, Beaumont Hospital, Dublin, Ireland.
The British Journal of Surgery
|October 1, 1992
Summary
Cytokine immunotherapy shows promise for treating cancers like melanoma and renal cell cancer. Future research focuses on reducing toxicity and enhancing efficacy through genetic modification for improved tumor management.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Cytokines are immune cell proteins with therapeutic potential in oncology.
- Key examples include interleukins, interferons, tumor necrosis factor, and colony-stimulating factors.
- These agents can elicit significant anti-tumor responses.
Purpose of the Study:
- To explore the therapeutic potential of cytokines in cancer treatment.
- To identify cancers with high response rates to cytokine immunotherapy.
- To investigate strategies for enhancing cytokine efficacy and reducing toxicity.
Main Methods:
- Review of clinical responses to cytokine immunotherapy.
- Exploration of genetic manipulation techniques for cytokine delivery.
- Analysis of current challenges in cytokine-based cancer therapy.
Main Results:
- Melanoma and renal cell cancer exhibit the highest response rates to cytokine immunotherapy.
- Genetic modification of tumor-infiltrating lymphocytes and tumor cells shows potential for increased therapeutic effects.
- Ongoing research aims to mitigate treatment-related toxicity.
Conclusions:
- Cytokine immunotherapy offers a viable treatment avenue for specific cancers.
- Genetic engineering presents a promising strategy to augment the efficacy of cytokine therapy.
- Further advancements are crucial for integrating immunotherapy into standard tumor management protocols.